Sabra Health Care REIT
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sabra Health Care REIT generated cash of $300,571,000, which is less than the previous year. Cash used in financing activities reached the amount of -$410,300,000 last year. Net change in cash is therefore -$7,213,000.
Cash Flow
| 2014 | 85.33M | -826.47M | 798.62M |
|---|---|---|---|
| 2015 | 121.10M | -489.22M | 314.07M |
| 2016 | 176.73M | 142.36M | -300.89M |
| 2017 | 133.48M | -240.07M | 598.81M |
| 2018 | 358.54M | -258.49M | -629.34M |
| 2019 | 372.47M | 262.84M | -646.18M |
| 2020 | 354.85M | -136.45M | -202.10M |
| 2021 | 356.39M | -336.19M | 30.14M |
| 2022 | 315.73M | -216.24M | -161.70M |
| 2023 | 300.57M | 103.13M | -410.3M |
SBRA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 53.93M | 115.88M | 65.52M | 49.14M | 59.65M | 587.44M | 25.66M | 7.43M | 61.79M | 4.30M |
Operating activities | ||||||||||
Net income | 13.75M | -77.60M | -113.25M | 138.41M | 69.01M | 279.11M | 158.36M | 70.20M | 79.38M | 46.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 183.08M | 187.78M | 178.99M | 176.73M | 181.54M | 199.08M | 112.97M | 68.47M | 63.07M | 43.33M |
Stock-based compensation expense | 7.91M | 7.45M | 7.91M | 7.90M | 9.81M | 7.64M | 8.35M | 7.49M | 6.12M | 9.85M |
| Deferred income tax benefit | 7.91M | 7.45M | 7.91M | 7.90M | 9.81M | 7.64M | 8.35M | 7.49M | 6.12M | 9.85M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -11.07M | -6.44M | 8.22M | -6.39M | -9.63M | -6.75M | -16.73M | -2.33M | -22.82M | 0 |
Inventories | 11.07M | 6.44M | -8.22M | 6.39M | 9.63M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 8.34M | -13.25M | 14.47M | 3.65M | -13.87M | -11.74M | -67.25M | 11.46M | 6.97M | 12.63M |
Cash generated by operating activities | 300.57M | 315.73M | 356.39M | 354.85M | 372.47M | 358.54M | 133.48M | 176.73M | 121.10M | 85.33M |
Investing activities | ||||||||||
Purchases Of Investments | -11.02M | -8.02M | -9.06M | -20.06M | -89.65M | -5.31M | -2.74M | -7.34M | -12.80M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -33.60M | -105.59M | 0 | 93.35M | -334.12M | 0 | 0 | 0 |
Acquisitions Net | -5.23M | -142.91M | -7.76M | -16.65M | 0 | -354.46M | 77.85M | -7.34M | -12.80M | -15.48M |
Cash generated by investing activities | 103.13M | -216.24M | -336.19M | -136.45M | 262.84M | -258.49M | -240.07M | 142.36M | -489.22M | -826.47M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 308.71M | 80.09M | 549.32M | 0 | 366.8M | 0 | 139.40M | 0 |
Payments for dividends | -277.44M | -277.15M | -262.91M | -278.29M | -335.43M | -325.22M | -182.08M | -119.26M | -109.89M | -81.48M |
Repurchases of common stock | -2.68M | -4.81M | -308.71M | -80.09M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -94.12M | 122.78M | -767.66M | -3.07M | -849.25M | -157.33M | 429.85M | -174.40M | 285.84M | 389.09M |
Cash used in financing activities | -410.3M | -161.70M | 30.14M | -202.10M | -646.18M | -629.34M | 598.81M | -300.89M | 314.07M | 798.62M |
Net Change In Cash | -7.21M | -61.95M | 50.36M | 16.38M | -10.51M | -527.79M | 492.96M | 18.22M | -54.35M | 57.48M |
Cash at end of period | 46.71M | 53.93M | 115.88M | 65.52M | 49.14M | 59.65M | 518.63M | 25.66M | 7.43M | 61.79M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |